1,261 Patients
With Suspected Non-ST-Segment Elevation Myocardial Infraction (NSTEMI)Point-of-Care High-Sensivity Cardiac Troponin I
Sensitivity Mesured at 0 h and 1 hTriage by 0/1 Hour-Algorithm
All-Cause Death of Patients Ruled-Out by the 0/1 h-Algorithm
0% at 30-Days and 1.6% at 2-Years of Follow-upImproved processes in the emergency room
A highly effective and very safe 0/1-h algorithm was derived and validated for TriageTrue.
“With the clinical availability of a POC-hs-cTnI-TriageTrue assay with an at least comparable diagnostic accuracy to the best-validated central laboratory hs-cTnT/I assays and a very safe and highly efficacious POC-hs-cTnI-TriageTrue 0/1-h algorithm, the time to diagnosis and to discharge from the ED can be expected to reduce even further than currently achieved with central laboratory -based hs-cTnT/I 0/1-h algorithms.“
“With the clinical availability of a POC-hs-cTnI-TriageTrue assay [...] the time to diagnosis and to discharge from the ED can be expected to reduce even further than currently achieved with central laboratory -based hs-cTnT/I 0/1-h algorithms.“
‘’Moreover, it would allow extending the use of the hs-cTnI 0/1-h algorithm to settings without a central laboratory including smaller hospitals, ambulances, and general practices.’’
Boeddinghaus, J. et al.,
J Am Coll Cardiol. 2020; 75(10):1111-24
Minimal effort — exceptional performance
Highly sensitive test results of laboratory quality
TriageTrue provides you with accurate results you can rely on at the point-of-care. That empowers you to decide on the right diagnosis with greater certainty.
Highly sensitive test results of laboratory quality
99th Percentile URL (CV %) | 20.5 ng/l overall (5.6%) |
Women: 14.4 ng/l (5.9%) Men: 25.7 ng/l (5.4%) |
10% CV Limit of Quantitation (LOQ) | 6.2 ng/l (Whole Blood) | 4.6 ng/l (Plasma) |
Limit of Detection (LOD) | 1.7 ng/l (Whole Blood) | 1.5 ng/l (Plasma) |
Percent of normal population > LOD |
72%*
* Normals and analytical sensitivity analyzed with same lot of TriageTrue |
99th Percentile URL (CV %) | 20.5 ng/l overall (5.6%) |
Women: 14.4 ng/l (5.9%) Men: 25.7 ng/l (5.4%) |
10% CV Limit of Quantitation (LOQ) | 6.2 ng/l (Whole Blood) | 4.6 ng/l (Plasma) |
Limit of Detection (LOD) | 1.7 ng/l (Whole Blood) | 1.5 ng/l (Plasma) |
Percent of normal population > LOD |
72%*
* Normals and analytical sensitivity analyzed with same lot of TriageTrue |
Test result in < 20 minutes
TriageTrue is easy to use, eliminates unnecessary detours through the lab, and provides test results as quickly as possible, directly at point-of-care. When you suspect a myocardial infarction, there is no time to lose.
Highly sensitive test results of laboratory quality
High diagnostic accuracy
‘’The diagnostic accuracy of the POC-hs-cTnI TriageTrue assay was very high and at least comparable to that provided by the best validated central laboratory-based hs-cTnT-Elecsys and hs-cTnI-Architect assays.’’ Boeddinghaus, J. et al., J Am Coll Cardiol. 2020: 75(10):1111-24
TriageTrue in the media
SCIENTIFIC ARTICLES
Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I
Spotlight on the new star at the Point-of-care
Highly sensitive Troponin I testing directly at point-of-care is finally possible with the new TriageTrue Test by Quidel. Thanks to a newly developed, innovative test device, TriageTrue achieves unprecedented precision and sensitivity on the proven Triage MeterPro. Stop compromising quality and speed and stay in control of ACS diagnostics with accurate quantitative results in less than 20 minutes. Right on cue – at point-of-care.
Co-starring
TriageTrue was specially developed for the proven Triage MeterPro. In addition to troponin, it can measure other relevant parameters, such as natriuretic peptides (BNP and NT-proBNP) or D-dimer. It can also be used for drug screening from urine samples. Benefit from a strong ensemble of assays and improve your acute care diagnosis.
LEARN MORE